Expression of PD-1 on T Cells in Patients with Chronic Hepatitis B at Early Phase of Antiviral Treatment

Jian CHENG,Jing SUN,Wensan ZHOU,Xiaomin YAN,Yong LIU,Lin XU,Jing WU,Li LIN,Chao WU

DOI: https://doi.org/10.3969/J.issn.1008-7125.2009.08.009

2009-01-01

Abstract:Background: Programmed death 1 (PD-1) on T cells is expressed persistently at a high level in chronic hepatitis B virus (HBV) infection, however, there are few studies focus on the change of PD-1 expression on T cells in patients with chronic hepatitis B (CHB) during antiviral therapy and its relationship with viral load. Aims: To observe longitudinally the PD-1 expression on CD4 + and CD8+ T cells in peripheral blood of CHB patients at early phase of antiviral therapy, and to explore the relationship between PD-1 expression and serum levels of HBV DNA and alanine aminotransferase (ALT). Methods: Levels of PD-1 expression on peripheral blood CD4+ and CD8+ T cells in 31 CHB patients undergoing antiviral therapy were assessed by flow cytometry prior to the treatment or at baseline (T1), and 4-8 weeks (T2) and 12-16 weeks (T3) during treatment course, respectively. Serum HBV DNA load was determined by real-time fluorescent quantitative polymerase chain reaction (PCR). Serum ALT level was also measured at the same time points. Results: A significant reduction in PD-1 expression level on both peripheral CD4+ and CD8+ T cells in CHB patients was observed at early phase of antiviral therapy (P<0.05). Serum HBV DNA and ALT levels were also markedly reduced from T1 to T3 (P<0.01). Furthermore, significant positive correlations between PD-1 expression on CD4+ and CD8 + T cells and HBV DNA load (P<0.01), and ALT level (P<0.05) were observed. Conclusions: Effective antiviral treatment induced reduction of viral load results in down-regulation of PD-1 expression on T cells in CHB patients. Furthermore, PD-1 expression on T cells is closely correlated with disease status.